COHERUS BIOSCIENCES ($CHRS) posted quarterly earnings results for Q1 2026 on Monday, May 11th. The company reported earnings of -$0.25 per share, beating estimates of -$0.28 by $0.03. The company also reported revenue of $12,310,000, missing estimates of $14,628,840 by $-2,318,840.
Stock price change since market close: -8.72%
You can see Quiver Quantitative's $CHRS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
COHERUS BIOSCIENCES Hedge Fund Activity
We have seen 63 institutional investors add shares of COHERUS BIOSCIENCES stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC removed 2,372,853 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $3,369,451
- MACQUARIE GROUP LTD removed 899,999 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,277,998
- MILLENNIUM MANAGEMENT LLC added 660,451 shares (+inf%) to their portfolio in Q4 2025, for an estimated $937,840
- GSA CAPITAL PARTNERS LLP added 477,481 shares (+inf%) to their portfolio in Q4 2025, for an estimated $678,023
- TWO SIGMA INVESTMENTS, LP added 468,163 shares (+1310.9%) to their portfolio in Q4 2025, for an estimated $664,791
- JANE STREET GROUP, LLC added 393,530 shares (+187.4%) to their portfolio in Q4 2025, for an estimated $558,812
- CITADEL ADVISORS LLC removed 331,155 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $470,240
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
COHERUS BIOSCIENCES Price Targets
Multiple analysts have issued price targets for $CHRS recently. We have seen 2 analysts offer price targets for $CHRS in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- An analyst from Guggenheim set a target price of $12.0 on 05/11/2026
- Jay Olson from Oppenheimer set a target price of $10.0 on 01/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
